Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-226978
Filing Date
2026-05-15
Accepted
2026-05-15 16:33:28
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-20260331.htm   iXBRL 10-Q 2055338
2 EX-3.8 pstv-ex3_8.htm EX-3.8 15966
3 EX-3.9 pstv-ex3_9.htm EX-3.9 16566
4 EX-3.13 pstv-ex3_13.htm EX-3.13 207971
5 EX-31.1 pstv-ex31_1.htm EX-31.1 15790
6 EX-31.2 pstv-ex31_2.htm EX-31.2 12675
7 EX-32.1 pstv-ex32_1.htm EX-32.1 18039
  Complete submission text file 0001193125-26-226978.txt   8981788

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20260331.xsd EX-101.SCH 1403027
72 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20260331_htm.xml XML 1343170
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 26988661
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)